Notice: Undefined property: JObject::$description in /home/movement/public_html/components/com_k2/templates/default/user.php on line 59
Source : National Geographic Channel
A drug that's already approved for treating leukemia appears to dramatically reduce symptoms in people who have Parkinson's disease with dementia, or a related condition called Lewy body dementia.
A pilot study of 12 patients given small doses of nilotinib found that movement and mental function improved in all of the 11 people who completed the six-month trial, researchers reported Saturday at the Society for Neuroscience meeting in Chicago.
Institute of Neurosciences of Apollo Hospitals, Bangalore, have started providing Deep brain stimulation (DBS), to patients with Parkinson’s disease and various other movement disorders. Parkinson’s disease, one of the commonest neurodegenerative disorders, whose prevalence has been increasing with increased life expectancy. Currently millions of people are suffering from Parkinson’s disease world wide and off late
it is being commonly recognized in India too. Unlike various other disorders, Parkinson’s disease has good therapeutic options to improve the quality of life. In April 2014, Apollo Hospitals, had launched exclusive Parkinson’s disease and Movement disorders clinic. This clinic is being run by Dr. Prashanth LK. Dr. Prashanth LK, is a neurologist, who is further specialized in Parkinson’s disease and other movement disorders. After successive launch of the clinic, they have recently conducted a first Deep Brain stimulation (DBS) procedure. The procedure involves installing a specialized stimulation device in the brain similar to cardiac pacemaker, which tries to modulate the brain functions. The surgery was conducted by Dr. Arun Naik and team. According to the Neurosciences team, DBS is a very effective therapy for patients with moderately advanced Parkinson’s disease, where in benefit of medications are limited by its side effects. The surgery is currently well approved therapy for Parkinson’s disease world wide and currently forms the standard of care in Parkinson’s disease therapeutic armamentarium.
we petition the obama administration to:
Dystonia is the third most common movement disorder but remains largely unknown to the public. Dystonia is a neurological disorder characterized by involuntary muscle contractions causing abnormal, often repetitive, movements and/or postures.